文献速递产科母胎医学

孕19-23周母体心脏功能对妊娠期糖尿病的预测价值

Maternal cardiac function at 19-23 weeks' gestation in prediction of gestational diabetes mellitus.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-06-01

这项前瞻性观察研究纳入2853例孕妇,其中199例(7.0%)发生妊娠期糖尿病(GDM)。在19+1至23+3周进行母体超声心动图检查,校正母体人口学特征和病史后,GDM组仅外周血管阻力和心肌性能指数轻微升高,但加入心血管指标并未改善基于母体因素的GDM筛查效果。

要点

  • GDM孕妇在诊断前已存在轻微心脏功能和血流动力学改变。
  • 这些改变主要与不良风险因素特征相关,而非GDM本身。
  • 20周母体心脏评估不能为GDM预测提供额外信息。

核心结论

  • GDM孕妇在发生GDM前存在轻微的功能和血流动力学心脏改变,但多与不良风险因素特征相关。
  • 20周母体心脏评估不能为基于人口学特征和病史计算的GDM预测提供额外信息。

研究设计与样本

  • 前瞻性观察研究,纳入2853例在19+1至23+3周进行常规医院访视的孕妇。
  • 访视包括记录母体人口学特征和病史,以及母体超声心动图评估心脏指标。

主要发现

  • 研究人群2853例妊娠中199例(7.0%)发生GDM。
  • GDM组与非GDM组在E/A比值、E/e'比值、心肌性能指数和整体纵向收缩应变存在显著差异。
  • 校正母体人口学特征和影响心脏指标的病史因素后,仅外周血管阻力和心肌性能指数在GDM组轻微升高。
  • 基于母体人口学特征和病史的GDM筛查效果未因加入心血管指标而改善。

关键数值与推荐

  • GDM组外周血管阻力和心肌性能指数在校正后轻微升高。
  • 筛查GDM的受试者工作特征曲线下面积和检出率在10%、20%和40%假阳性率下确定,但未报告具体数值。

临床怎么用

  • 20周常规母体心脏评估不推荐用于改善GDM预测。
  • GDM风险评估应基于母体人口学特征和病史。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine differences in maternal cardiovascular indices at 19-23 weeks' gestation between pregnancies that develop gestational diabetes mellitus (GDM) and those without GDM, and to determine whether such cardiovascular changes are the consequence of maternal demographic characteristics and medical history or GDM per se. METHODS: This was a prospective observational study in women attending for a routine hospital visit at 19 + 1 to 23 + 3 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, and maternal echocardiography for assessment of E/A ratio, E/e' ratio, myocardial performance index, global longitudinal systolic strain, left ventricular ejection fraction, peripheral vascular resistance, left ventricular cardiac output and left ventricular mass indexed for body surface area. The measurements of the maternal cardiac indices were standardized to remove the effects of maternal characteristics and elements from the medical history, and the adjusted values in the GDM group were compared to those in the non-GDM group. Likelihood ratios were derived for those indices that were altered significantly in GDM, and these were used to modify the prior risk derived from maternal demographic characteristics and medical history. The area under the receiver-operating-characteristics curve and the detection rate of GDM, at 10%, 20% and 40% false-positive rates, in screening by a combination of maternal factors with cardiovascular indices were determined. RESULTS: The study population of 2853 pregnancies contained 199 (7.0%) that developed GDM. In pregnancies that developed GDM, there were significant differences from the non-GDM group in E/A ratio, E/e' ratio, myocardial performance index and global longitudinal systolic strain. After adjustment for maternal demographic characteristics and factors from the medical history known to affect cardiac indices, the only cardiovascular indices that were significantly different between the GDM and non-GDM groups were peripheral vascular resistance and myocardial performance index, both of which were marginally increased in the GDM group. The performance of screening for GDM by maternal demographic characteristics and medical history was not improved by the addition of cardiovascular indices. CONCLUSIONS: Women with GDM have subtle functional and hemodynamic cardiac changes prior to the development of GDM. These cardiac changes are mostly related to the adverse risk-factor profile of these women. Maternal cardiac assessment at 20 weeks does not offer additional predictive information for GDM development in pregnancy to that calculated based on demographic characteristics and medical history. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gibbone E, Wright A, Campos RV, et al. Maternal cardiac function at 19-23 weeks' gestation in prediction of gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2021. PMID: 33428303. doi:10.1002/uog.23589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。